Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05933577 |
Title | A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NZL | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS |